Drug intelligence / Profile preview

ursodeoxycholic acid

Development stage
Approved
Lead developer
TPG Capital
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ursodeoxycholic acid (UDCA), also known as ursodiol or 熊脱氧胆酸 in Chinese, is a naturally occurring secondary bile acid used primarily for the treatment of primary biliary cholangitis (PBC; formerly called primary biliary cirrhosis) and for the dissolution and prevention of cholesterol gallstones. It works by reducing the cholesterol saturation of bile and replacing more toxic hydrophobic bile acids in the bile pool. This leads to gradual dissolution of cholesterol-rich gallstones and reduces liver damage in cholestatic liver diseases. UDCA is also used off-label for other cholestatic conditions such as biliary atresia and intrahepatic cholestasis[1][2][3][4][5].

Brand names
ActigallUrsoUrso 250Urso250Urso-250Urso ForteReltone
Other names
ursodiol(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
02

Targets

FXR (Farnesoid x-activated receptor)

Beyond the preview

Go deeper on ursodeoxycholic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ursodeoxycholic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call